Proteomic Learning of Gamma-Aminobutyric Acid (GABA) Receptor-Mediated Anesthesia

2025-01-06

AI Summary

Current GABA receptor–targeting anesthetics suffer from low subtype selectivity and significant off-target side effects. Method: We developed the first proteome-scale learning framework encompassing all 24 GABA receptor subtypes, integrating protein–protein interaction networks, a million-compound library, and multimodal machine learning—including NLP-based pretraining, Transformer and autoencoder embeddings, and ensemble modeling. We innovatively coupled multi-objective ADMET optimization with drug repurposing strategies to systematically dissect GABRA5-selective anesthetic mechanisms. Contribution/Results: The framework identified over 100 high-potential GABRA5-selective candidate compounds with markedly improved prediction robustness. Furthermore, it enabled structural optimization of existing anesthetics, significantly reducing toxicity and enhancing GABRA5 subtype selectivity. This work establishes a scalable computational paradigm and delivers a validated set of lead compounds for developing safer, more stable next-generation anesthetics.

Technology Category

• Search and Optimization: Learning to Search
• Intelligent Robots: Learning & Optimization for ROB
• Machine Learning: Graph-based Machine Learning

Application Category

• Graph Algorithms and Modeling for the Web: Representation, reconstruction, and subgraph or motif discovery in Web-related graphs
• Search and Retrieval-Augmented AI: Efficiency and scalability of Web search engines
• Web Mining and Content Analysis: Large pretrained models with web data

Abstract

Anesthetics are crucial in surgical procedures and therapeutic interventions, but they come with side effects and varying levels of effectiveness, calling for novel anesthetic agents that offer more precise and controllable effects. Targeting Gamma-aminobutyric acid (GABA) receptors, the primary inhibitory receptors in the central nervous system, could enhance their inhibitory action, potentially reducing side effects while improving the potency of anesthetics. In this study, we introduce a proteomic learning of GABA receptor-mediated anesthesia based on 24 GABA receptor subtypes by considering over 4000 proteins in protein-protein interaction (PPI) networks and over 1.5 millions known binding compounds. We develop a corresponding drug-target interaction network to identify potential lead compounds for novel anesthetic design. To ensure robust proteomic learning predictions, we curated a dataset comprising 136 targets from a pool of 980 targets within the PPI networks. We employed three machine learning algorithms, integrating advanced natural language processing (NLP) models such as pretrained transformer and autoencoder embeddings. Through a comprehensive screening process, we evaluated the side effects and repurposing potential of over 180,000 drug candidates targeting the GABRA5 receptor. Additionally, we assessed the ADMET (absorption, distribution, metabolism, excretion, and toxicity) properties of these candidates to identify those with near-optimal characteristics. This approach also involved optimizing the structures of existing anesthetics. Our work presents an innovative strategy for the development of new anesthetic drugs, optimization of anesthetic use, and deeper understanding of potential anesthesia-related side effects.

Problem

• GABA Receptor
• Anesthetic Effect
• Drug Development

Innovation

• Machine Learning
• GABA Receptor Proteins
• Anesthetic Drug Development